Gamma Knife Market Size, Share, Industry Trends and Forecast to 2030

Gamma Knife Market Size & CAGR in 2021

The global Gamma Knife market is estimated to have a market size of USD 145.6 million in 2021, with a Compound Annual Growth Rate (CAGR) of 4.5% from 2021 to 2026. The increasing prevalence of brain disorders and the advancements in non-invasive surgical procedures are driving the growth of the Gamma Knife market.

COVID-19 Impact on the Gamma Knife Market

The COVID-19 pandemic had a mixed impact on the Gamma Knife market. On one hand, the lockdowns and restrictions on elective surgeries led to a temporary decline in the number of procedures performed using Gamma Knife. However, the increased focus on non-invasive treatments and the need to reduce hospital visits favored the adoption of Gamma Knife procedures. As the healthcare industry recovers from the pandemic, the demand for Gamma Knife is expected to grow steadily.

Gamma Knife Dynamics

Gamma Knife is a non-invasive treatment option for brain disorders such as tumors, arteriovenous malformations, and trigeminal neuralgia. It uses precise beams of radiation to target the affected area in the brain while sparing the surrounding healthy tissue. The technology offers high success rates, minimal side effects, and shorter recovery times compared to traditional surgical methods.

Segments and Related Analysis

The Gamma Knife market can be segmented based on technology type, indication, and end-user. The technology types include Leksell Gamma Knife Perfexion, Leksell Gamma Knife Icon, and others. Indications for Gamma Knife procedures include brain tumors, trigeminal neuralgia, and others. End-users of Gamma Knife technology are hospitals, clinics, and ambulatory surgery centers.

By Region Analysis

The Gamma Knife market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the dominant region in the market due to a high prevalence of brain disorders, technological advancements, and well-established healthcare infrastructure. The Asia Pacific region is expected to witness significant growth in the coming years due to the increasing adoption of Gamma Knife technology in countries like China and India.

Key Market Players and Competitive Landscape

Some of the key players in the Gamma Knife market include Elekta AB, Varian Medical Systems, Inc., Alpha Tau Medical Ltd., and Isoray. These companies are focusing on product innovation, strategic partnerships, and mergers & acquisitions to gain a competitive edge in the market. The increasing investment in research and development activities is expected to drive the growth of the Gamma Knife market.

Recent Happenings in the Gamma Knife Market

In recent developments, Elekta AB launched the Elekta Unity MR-Linac system, combining magnetic resonance imaging (MRI) and radiation therapy, offering personalized cancer care. Varian Medical Systems, Inc. introduced the Ethos therapy system, providing adaptive treatment planning and delivery for enhanced precision. Alpha Tau Medical Ltd. announced positive results from a clinical trial for its targeted Alpha Radiation Technology. Isoray received FDA clearance for its Cesium-131 Brachytherapy for the treatment of brain tumors. These advancements highlight the evolving landscape of the Gamma Knife market.